90 phenotypes from 10 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cd44M1Btlr/Cd44M1Btlr C57BL/6J-Cd44M1Btlr	alopecia	J:267484
	decreased alpha-beta T cell number	J:267483
	decreased CD4-positive, alpha-beta T cell number	J:267483
	decreased CD8-positive, alpha-beta T cell number	J:267483
	decreased central memory CD4-positive, alpha-beta T cell number	J:267483
	decreased central memory CD8 positive, alpha-beta T cell number	J:267483
	decreased effector memory CD4-positive, alpha-beta T cell number	J:267483
Cd44tm1.1Ugu/Cd44tm1.1Ugu B6.129(Cg)-Cd44tm1.1Ugu	decreased susceptibility to experimental autoimmune encephalomyelitis	J:199279
Cd44tm1.1Ugu/Cd44tm1.1Ugu involves: 129/Sv * C57BL/6	abnormal digestive system physiology	J:62867
	abnormal T-helper 1 physiology	J:62867
	abnormal T-helper 2 physiology	J:62867
	normal immune system phenotype	J:62867
Cd44tm1.1Ugu/Cd44tm1.1Ugu SJL.129(Cg)-Cd44tm1.1Ugu	decreased susceptibility to experimental autoimmune encephalomyelitis	J:199279
	decreased T cell proliferation	J:199279
Cd44tm1Hbg/Cd44tm1Hbg B6.129-Cd44tm1Hbg	decreased mast cell histamine storage	J:146846
	decreased mast cell number	J:146846
Cd44tm1Hbg/Cd44tm1Hbg involves: 129S1/Sv * 129X1/SvJ	abnormal epidermal lamellar body morphology	J:108938
	abnormal lipid level	J:108938
	abnormal osteoclast differentiation	J:101563
	abnormal response to cardiac infarction	J:131974
	abnormal response to infection	J:86947
	decreased cholesterol level	J:108938
	impaired skin barrier function	J:108938
	impaired wound healing	J:131974
	increased acute inflammation	J:131974
	increased diameter of tibia	J:101563
	short tibia	J:101563
	thin epidermis	J:108938
Cd44tm1Hbg/Cd44tm1Hbg involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal CD4-positive, alpha beta T cell morphology	J:68069
	abnormal CD8-positive, alpha beta T cell morphology	J:68069
	abnormal leukocyte migration	J:68069
	abnormal neutrophil physiology	J:94850
	choroidal neovascularization	J:154560
	normal hematopoietic system phenotype	J:110964
Cd44tm1Mak/Cd44+ involves: 129P2/OlaHsd * C57BL/6J	abnormal leukocyte migration	J:99032
Cd44tm1Mak/Cd44tm1Mak B6.129P2-Cd44tm1Mak	abnormal circulating cytokine level	J:69351
	abnormal leukocyte migration	J:108245
	decreased activation-induced cell death of T cells	J:69351
	decreased myocardial infarct size	J:80446
	decreased sensitivity to induced cell death	J:69351
	decreased transforming growth factor beta level	J:111216
	enhanced coordination	J:80446
	impaired macrophage phagocytosis	J:111216
	impaired natural killer cell mediated cytotoxicity	J:110889
	increased circulating interferon-gamma level	J:69351
	increased circulating interleukin-2 level	J:69351
	increased circulating tumor necrosis factor level	J:69351
	increased mean systemic arterial blood pressure	J:80446
	increased susceptibility to induced morbidity/mortality	J:69351, J:111216
	liver inflammation	J:69351
	lung inflammation	J:108245, J:111216
Cd44tm1Mak/Cd44tm1Mak D1.129P2-Cd44tm1Mak	increased susceptibility to induced arthritis	J:95275
Cd44tm1Mak/Cd44tm1Mak involves: 129P2/OlaHsd * C57BL/6	abnormal chemokine secretion	J:155691
	abnormal circulating chemokine level	J:155691
	abnormal interleukin secretion	J:155691
	abnormal miniature excitatory postsynaptic currents	J:128984
	abnormal physiological neovascularization	J:110162
	abnormal vascular endothelial cell morphology	J:110162
	abnormal vascular endothelial cell physiology	J:110162
	abnormal vasculogenesis	J:110162
	decreased acute inflammation	J:114341
	decreased angiogenesis	J:110162
	decreased blood urea nitrogen level	J:114341
	decreased circulating creatinine level	J:114341
	decreased circulating tumor necrosis factor level	J:155691
	decreased miniature excitatory postsynaptic current frequency	J:128984
	decreased susceptibility to kidney reperfusion injury	J:114341
	decreased tumor growth/size	J:110162
	delayed wound healing	J:110162
	increased interleukin-1 beta secretion	J:155691
	increased interleukin-6 secretion	J:155691
	increased interleukin-10 secretion	J:155691
	increased miniature excitatory postsynaptic current amplitude	J:128984
	increased tumor necrosis factor secretion	J:155691
	peritoneal inflammation	J:155691
Cd44tm1Mak/Cd44tm1Mak involves: 129P2/OlaHsd * C57BL/6J	abnormal cell morphology	J:105319
	abnormal cell physiology	J:72658
	abnormal definitive hematopoiesis	J:72658
	abnormal leukocyte migration	J:99032
	abnormal mitochondrial crista morphology	J:105319
	abnormal vascular smooth muscle physiology	J:101783
	decreased fibroblast proliferation	J:105319
	normal immune system phenotype	J:72658
	increased mitochondrial size	J:105319
	increased susceptibility to parasitic infection	J:72658
Cd44tm1Stpa/Cd44tm1Stpa B6.Cg-Cd44tm1Stpa	normal digestive/alimentary phenotype	J:204874
Cd44tm1Ugu/Cd44tm1Ugu involves: 129/Sv * C57BL/6	abnormal digestive system physiology	J:62867
	abnormal T-helper 1 physiology	J:62867
	abnormal T-helper 2 physiology	J:62867
	normal immune system phenotype	J:62867
Cd44tm2.1Ugu/Cd44tm2.1Ugu B6.129-Cd44tm2.1Ugu	decreased susceptibility to experimental autoimmune encephalomyelitis	J:199279
	decreased T cell proliferation	J:199279
Cd44tm2Kmz/Cd44tm2Kmz DBA/1LacJ-Cd44tm2Kmz	abnormal involution of the mammary gland	J:74524
	abnormal uterus morphology	J:74524
	decreased susceptibility to induced arthritis	J:74268
Cd44tm2Kmz/Cd44tm2Kmz involves: BALB/c * DBA/1	abnormal CD4-positive, alpha-beta T cell physiology	J:114317
	abnormal leukocyte adhesion	J:114317
	decreased susceptibility to type IV hypersensitivity reaction	J:114317
	impaired leukocyte tethering or rolling	J:114317
	impaired neutrophil recruitment	J:114317
Cd44tm2Stpa/Cd44tm2Stpa B6.Cg-Cd44tm2Stpa	normal digestive/alimentary phenotype	J:204874
Cd44tm2Ugu/Cd44tm2Ugu involves: 129S1/Sv * 129X1/SvJ	no abnormal phenotype detected	J:108416